Matches in Nanopublications for { ?s ?p "[We have recently identified an EGFR mutation E884K, in combination with L858R, in a patient with advanced lung cancer who progressed on erlotinib maintenance therapy, and subsequently had leptomeningeal metastases that responded to gefitinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- assertion description "[We have recently identified an EGFR mutation E884K, in combination with L858R, in a patient with advanced lung cancer who progressed on erlotinib maintenance therapy, and subsequently had leptomeningeal metastases that responded to gefitinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We have recently identified an EGFR mutation E884K, in combination with L858R, in a patient with advanced lung cancer who progressed on erlotinib maintenance therapy, and subsequently had leptomeningeal metastases that responded to gefitinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We have recently identified an EGFR mutation E884K, in combination with L858R, in a patient with advanced lung cancer who progressed on erlotinib maintenance therapy, and subsequently had leptomeningeal metastases that responded to gefitinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We have recently identified an EGFR mutation E884K, in combination with L858R, in a patient with advanced lung cancer who progressed on erlotinib maintenance therapy, and subsequently had leptomeningeal metastases that responded to gefitinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP486986.RAIokYOf6CTp-ojlU9ElJgaeB7i4XtW64ukqbhB5W-vUU130_assertion description "[We have recently identified an EGFR mutation E884K, in combination with L858R, in a patient with advanced lung cancer who progressed on erlotinib maintenance therapy, and subsequently had leptomeningeal metastases that responded to gefitinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP486986.RAIokYOf6CTp-ojlU9ElJgaeB7i4XtW64ukqbhB5W-vUU130_provenance.
- NP704070.RADWX95l5wq0An3SOQ5ZED6DR6qPY2S1_FT4F_B7P-bf8130_assertion description "[We have recently identified an EGFR mutation E884K, in combination with L858R, in a patient with advanced lung cancer who progressed on erlotinib maintenance therapy, and subsequently had leptomeningeal metastases that responded to gefitinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP704070.RADWX95l5wq0An3SOQ5ZED6DR6qPY2S1_FT4F_B7P-bf8130_provenance.
- NP704071.RACtKmUAfAbsOoQnweu4c_7jwdDzsRagGtMSKFIOaJNNQ130_assertion description "[We have recently identified an EGFR mutation E884K, in combination with L858R, in a patient with advanced lung cancer who progressed on erlotinib maintenance therapy, and subsequently had leptomeningeal metastases that responded to gefitinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP704071.RACtKmUAfAbsOoQnweu4c_7jwdDzsRagGtMSKFIOaJNNQ130_provenance.
- NP370559.RA_3iDXg0lN5PotcCnZAlOA_SSH3aa4IbpUn_2vuXlQjw130_assertion description "[We have recently identified an EGFR mutation E884K, in combination with L858R, in a patient with advanced lung cancer who progressed on erlotinib maintenance therapy, and subsequently had leptomeningeal metastases that responded to gefitinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP370559.RA_3iDXg0lN5PotcCnZAlOA_SSH3aa4IbpUn_2vuXlQjw130_provenance.
- NP704069.RAGfxkaQcXPl0CN0LjJpiBpzmCPwodSs8OmetapkCAMXY130_assertion description "[We have recently identified an EGFR mutation E884K, in combination with L858R, in a patient with advanced lung cancer who progressed on erlotinib maintenance therapy, and subsequently had leptomeningeal metastases that responded to gefitinib.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP704069.RAGfxkaQcXPl0CN0LjJpiBpzmCPwodSs8OmetapkCAMXY130_provenance.